STERIS plc logo
STESTERIS plc

Debt to Equity Ratio: 0.29

Is the debt to equity ratio high or low?

The debt to equity ratio of 0.29 is 36% below its 5-year average of 0.46, near the low end of its 5-year range (0.29–0.59).

As of Friday, June 26, 2026. 3.26% below its 12-month average of 0.30.

Debt to Equity

STE Debt to Equity Ratio

0.29

Reported quarterly debt to equity ratio; no daily interpolation.

-50.24% 5Y
STE Debt to Equity Ratio

STE Average Debt to Equity Ratio Chart

STE Debt to Equity Ratio

STE Current vs Average Debt to Equity Ratio Chart

STE Debt to Equity Ratio Metrics

DEBT TO EQUITY RATIO

0.29

DEBT TO EQUITY RATIO AVG TTM

0.30

DEBT TO EQUITY RATIO AVG 3Y

0.41

DEBT TO EQUITY RATIO AVG 5Y

0.46

DEBT TO EQUITY RATIO AVG 10Y

0.45

DEBT TO EQUITY RATIO AVG 15Y

0.46

DEBT TO EQUITY RATIO AVG 20Y

0.40

CURRENT VS TTM AVG

-3.26%

CURRENT VS 3Y AVG

-29.15%

CURRENT VS 5Y AVG

-36.15%

CURRENT VS 10Y AVG

-35.04%

CURRENT VS 15Y AVG

-36.18%

CURRENT VS 20Y AVG

-28.09%

STE Competitors' Debt to Equity Ratio

NAMEMARKET CAPDEBT TO EQUITY RATIOTTM3Y5Y
STERIS plc (STE)$21.00B0.290.300.410.46
Labcorp Holdings Inc. (LH)vs ›$22.26B0.840.870.780.74
Incyte Corporation (INCY)vs ›$22.73B0.010.010.010.01
Viatris Inc. (VTRS)vs ›$19.02B1.000.890.900.98
United Therapeutics Corporation (UTHR)vs ›$23.03B0.000.030.090.13
BioNTech SE (BNTX)vs ›$23.07B0.010.010.010.04
Quest Diagnostics Incorporated (DGX)vs ›$23.08B0.961.000.920.85
Zimmer Biomet Holdings, Inc. (ZBH)vs ›$18.01B0.590.540.510.54
Waters Corporation (WAT)vs ›$24.41B0.580.761.732.93
West Pharmaceutical Services, Inc. (WST)vs ›$24.79B0.130.120.120.13

Financial Health

Debt/Equity

0.29

Current Ratio

2.09

Debt to Equity Ratio Formula & Definition

Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Debt to Equity Ratio FAQ

What is the debt to equity ratio for STERIS plc (STE)?
The debt to equity ratio for STE stock is 0.29.
Is STERIS plc's debt to equity ratio high or low?
The debt to equity ratio of 0.29 is 36% below its 5-year average of 0.46, near the low end of its 5-year range (0.29–0.59).
What is the TTM average debt to equity ratio for STERIS plc (STE)?
The TTM average debt to equity ratio for STE stock is 0.30.
What is the 3Y average debt to equity ratio for STERIS plc (STE)?
The 3Y average debt to equity ratio for STE stock is 0.41.
What is the 5Y average debt to equity ratio for STERIS plc (STE)?
The 5Y average debt to equity ratio for STE stock is 0.46.
What is the 10Y average debt to equity ratio for STERIS plc (STE)?
The 10Y average debt to equity ratio for STE stock is 0.45.
What is the 15Y average debt to equity ratio for STERIS plc (STE)?
The 15Y average debt to equity ratio for STE stock is 0.46.
What is the 20Y average debt to equity ratio for STERIS plc (STE)?
The 20Y average debt to equity ratio for STE stock is 0.40.

STE Debt to Equity Ratio History

DATEDEBT TO EQUITY RATIO
2026-03-310.29
2025-12-310.29
2025-09-300.29
2025-06-300.30
2025-03-310.33
2024-12-310.36
2024-09-300.36
2024-06-300.39
2024-03-310.54
2023-12-310.55
2023-09-300.59
2023-06-300.51
2023-03-310.53
2022-12-310.54
2022-09-300.55
2022-06-300.50
2022-03-310.50
2021-12-310.53
2021-09-300.56
2021-06-300.58
2021-03-310.46
2020-12-310.48
2020-09-300.32
2020-06-300.35
2020-03-310.38
2019-12-310.37
2019-09-300.40
2019-06-300.41
2019-03-310.37
2018-12-310.40
2018-09-300.41
2018-06-300.43
2018-03-310.41
2017-12-310.46
2017-09-300.48
2017-06-300.51
2017-03-310.53
2016-12-310.55
2016-09-300.50
2016-06-300.51
2016-03-310.52
2015-12-310.55
2015-09-300.76
2015-06-300.63
2015-03-310.58
2014-12-310.57
2014-09-300.58
2014-06-300.62
2014-03-310.48
2013-12-310.47
2013-09-300.51
2013-06-300.53
2013-03-310.52
2012-12-310.57
2012-09-300.49
2012-06-300.25
2012-03-310.26
2011-12-310.27
2011-09-300.27
2011-06-300.26
2011-03-310.27
2010-12-310.28
2010-09-300.29
2010-06-300.30
2010-03-310.28
2009-12-310.42
2009-09-300.26
2009-06-300.28
2009-03-310.29
2008-12-310.29
2008-09-300.34
2008-06-300.25
2008-03-310.25
2007-12-310.18
2007-09-300.16
2007-06-300.14
2007-03-310.13
2006-12-310.17
2006-09-300.21
2006-06-300.27
2006-03-310.16
2005-12-310.15
2005-09-300.15
2005-06-300.18
2005-03-310.14
2004-12-310.14
2004-09-300.16
2004-06-300.16
2004-03-310.17
2003-12-310.18
2003-09-300.17
2003-06-300.20
2003-03-310.11
2002-12-310.16
2002-09-300.20
2002-06-300.22

About STERIS plc

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.

Dublin, DU
17,937 employees
Healthcare / Medical - Specialties
Sector
Healthcare
Industry
Medical - Specialties
CEO
Daniel A. Carestio